CytoDyn Engages Leading CRO For Phase II Inflammation Trial
VANCOUVER, Washington, Aug. 23, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab,...
VANCOUVER, Washington, Aug. 23, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab,...
Hangzhou, China, Aug. 23, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (the "Company"), a supplier of medical devices...
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial...
WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - August 23, 2024) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB:...
CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from...
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- The global electronic health records market size is estimated to grow by USD...
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- The global cerebral and tissue oximetry devices market size is estimated to grow by...